Teva Beats Q3 Earnings Expectations, Updates Outlook By: TalkMarkets October 31, 2014 at 18:52 PM EDT Third quarter revenues remained flat at $5.058 billion, slightly below the Zacks Consensus Estimate of $5.100 billion. Read More >> Related Stocks: Teva Pharmaceutical Industries ADR